Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Ketanserin MeSH Descriptor Data 2025


MeSH Heading
Ketanserin
Tree Number(s)
D03.383.621.365
D03.633.100.786.830.333
Unique ID
D007650
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D007650
Scope Note
A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
Entry Term(s)
3-(2-(4-(4-Fluorobenzoyl)piperidinol)ethyl)-2,4(1H,3H)-quinazolinedione
R-41,468
R-41468
Pharm Action
Antihypertensive Agents
Platelet Aggregation Inhibitors
Serotonin Antagonists
Registry Numbers
97F9DE4CT4
0
Related Numbers
74050-98-9
CAS Type 1 Name
2,4(1H,3H)-Quinazolinedione, 3-(2-(4-(4-fluorobenzoyl)-1-piperidinyl)ethyl)-
Previous Indexing
Piperidines (1966-1986)
Public MeSH Note
87
History Note
87
Date Established
1987/01/01
Date of Entry
1986/04/09
Revision Date
2016/05/31
Ketanserin Preferred
R-41,468 Narrower
page delivered in 0.141s